“Thank you Chen immigration team and my Attorney Anthony. It’s a great pleasure working with you as well I got my O1A visa approved in a very timely manner and you guys filed it on time. I sincerely thank Mr. Anthony for his great support and guiding me correctly and for answering all my questions to the point.”

Case Summary:

A postdoctoral fellow from India in the field of molecular biology is one of the few top cells and vascular biology experts, who has achieved a constant noteworthy record of success and influence in these areas of study. He is especially well-known for his research into an antiphospholipid syndrome. He hired North America Immigration Law Group to help him concoct a reliable O1A (Individual with Extraordinary Ability or Achievement) case on his behalf to prove how he has spent years investigating issues related to complement activation, tRNA and oxidative stress, and the mechanics of proteins in antiphospholipid syndrome and cancer and is regarded as an authority in the field, addressing our nation’s crucial issues, including the need for effective treatments against antiphospholipid syndrome and cancer.

Since we have a successful record of approved I-140 & I-129 cases, we were sure after evaluating our client’s credentials that he would achieve the O1A visa since he demonstrated a sustained status of national or international acclaim, as well as recognition for successes received in their field of molecular biology. We justified the same by outlining the active engagement of his peers in his work i.e., the 12 peer-reviewed scientific articles published in international journals, attracting a wide audience. We specified that his publications gathered 348 citations by researchers both in the United States and abroad, almost from 40 countries to be precise. These researchers hail from well-known international institutions, confirming our client’s major influence in the field.

Our client has also played an important role on the other side of the publishing process, where he has served as a peer reviewer for many highly respected journals. Since peer review service is restricted to only those researchers who have an extensive record of success in the field, thus we noted that the field has very well recognized our client’s authority by inviting him to review and evaluate the work of his peers no fewer than 30 times which further underscores the advantages and scale of his scholarly contributions and career achievements in the field of molecular biology.

To corroborate our client’s intensive background which has successfully prepared him to conduct groundbreaking research in the field of molecular biology, four fellow experts agreed to sign his recommendation letters, and one of them stated the following:

“As a fellow researcher studying advances in the treatment of antiphospholipid syndrome, I feel confident in supporting [client’s] considerable talents as they align with American interests, especially considering the high rate of mortality associated with CAPS and its effect on vulnerable populations. His work has yielded valuable results and his research should be considered indispensable within the United States.”

Considering his contributions to the field are accurate and informative, his results are unparalleled in the field, which is why his research was further supported by funding from the National Institutes of Health Support of Competitive Research (SCORE) Program and the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI). This funding supports projects that further the National Institutes of Health’s mission of improving the health and life expectancy of people in the United States by reducing the presence of disease and disability. Therefore, his research apparently encourages public health in the United States by aiding in the development of more effective treatments and therapies for illnesses, and his research must be allowed to continue in the United States.

Having the aforementioned, we are delighted that our exhibition of our client’s O1A case was thriving, hence he received his O-1A petition approval in just 5 days. We thank our team and our client for collaborating throughout this successful journey. Also, we would like to give a special thanks to the premium processing upgrade, which is a paid option offered by the USCIS that allows petitioners to enjoy accelerated adjudication (the case will be processed within 15 days instead of 9-12 months).